メニュー  → 生薬成分の代謝  → 
Abrusin 2”-O-β-D-apioside
Abrusin 2”-O-β-D-apioside

化合物名 Abrusin 2”-O-β-D-apioside 
動物種 ヒト腸内細菌フローラ 
代謝パラメータ  
代謝物 abrusin 2''-O-β-D-apioside
Abrusin
1-(2,6-dihydroxy-3,4-dimethoxy-5-((2R,3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)-3-(4-hydroxyphenyl)propan-1-one
1-(2', 6'-Dihydroxyl-3', 4'-dimethoxyphenyl)-3-(4''-hydroxyphenyl)propan-1-one
5,6-Dimethoxybenzene-1,3-diol
3-(4'-Hydroxyphenyl)propionic Acid
3-Phenylpropionic Acid
関連生薬  
参考文献 1) Li Y., Meselhy M. R., Wang L., Ma C., Nakamura N., and Hattori M.: Biotransformation of a C-glycosylflavone, abrusin 2"-O-β-D-apioside, by human intestinal bacteria. Chem. Pharm. Bull., 48, 1239-1241 (2000). 
論文備考 Time course of the transformation of abrusin 2"-O-β-D-apioside (1)
Abrusin 2"-O-β-D-apioside (1, 10 mmol in 200 ml DMSO) was added to a human fecal suspension (5%, 3.8 ml) and incubated at 37°C in an anaerobic incubator. Samples were picked up at intervals and extracted with BuOH (saturated with water and acidified with CH3COOH, 200 ml). After centrifugation at 8,800 × g for 5 min, 100 ml of the BuOH layer was evaporated in vacuo to give a residue. The residue was dissolved in MeOH (100 ml) and filtered through a Gelman filter (0.45 μm). The metabolites in the MeOH filtrate were analyzed by HPLC using calibration lines obtained with isolated compounds (5 and 6) or authentic samples (1, 2, 7 and 8). [Li et al., Chem. Pharm. Bull., 48, 1239-1241 (2000)] 
 

TOPICS

遺伝子解析情報

活性試験情報

生薬成分の代謝情報

伝統医薬データベース


富山大学和漢医薬学総合研究所
研究開発部門
資源開発分野
資源科学領域
〒930-0194
富山県富山市杉谷 2630
TEL: 076-434-7601
FAX: 076-434-5064